The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of the difference of prognosis between unresectable and recurrent biliary tract cancer: Kansai Hepatobiliary Oncology Group (KHBO) 1001.
Masashi Kanai
No relevant relationships to disclose
Kenji Ikezawa
No relevant relationships to disclose
Tetsuo Ajiki
No relevant relationships to disclose
Tadashi Tsukamoto
No relevant relationships to disclose
Hideyoshi Toyokawa
No relevant relationships to disclose
Hiroaki Terajima
No relevant relationships to disclose
Hiroaki Furuyama
No relevant relationships to disclose
Hiroaki Nagano
No relevant relationships to disclose
Iwao Ikai
No relevant relationships to disclose
Nobukazu Kuroda
No relevant relationships to disclose
Hiroaki Awane
No relevant relationships to disclose
Toshiya Ochiai
No relevant relationships to disclose
Shigekazu Takemura
No relevant relationships to disclose
Atsushi Miyamoto
No relevant relationships to disclose
Makoto Kume
No relevant relationships to disclose
Masao Ogawa
No relevant relationships to disclose
Yutaka Takeda
No relevant relationships to disclose
Kaoru Taira
No relevant relationships to disclose
Tatsuya Ioka
No relevant relationships to disclose